Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlobeImmune Inc (NASDAQ:GBIM)

2.47
Delayed Data
As of 3:59pm ET
 -0.11 / -4.26%
Today’s Change
1.43
Today|||52-Week Range
11.16
-67.46%
Year-to-Date
No recent news for GlobeImmune Inc.

Today’s Trading

Previous close2.58
Today’s open2.61
Day’s range2.45 - 2.83
Volume13,761
Average volume (3 months)62,430
Market cap$14.8M
Dividend yield--
Data as of 3:59pm ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)-572.52%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-73.50%
P/E ratioNM
Price/Sales3.71
Price/Book2.65

Competitors

 Today’s
change
Today’s
% change
APPYVenaxis Inc+0.02+4.15%
GALTUGalectin Therapeutic...-0.60-10.36%
AVDXAvant Diagnostics In...+0.02+7.14%
GBSNGreat Basin Scientif...-0.09-30.00%
Data as of 3:59pm ET, 09/02/2015

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$6.0M
Annual profit (last year)-$16.3M
Net profit margin-272.54%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Timothy C. Rodell
Secretary, Treasurer &
Vice President-Finance
C. Jeffrey Dekker
Corporate headquarters
Louisville, Colorado

Forecasts

Partner Offers